Task: Answer the multiple-choice question.
Question: Which compound exhibits a -56.731\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: CC1CCCN(C(=S)NC2CCCC2)C1
b: CC(=O)Nc1cccc(Oc2ccc3c(c2)C(=O)NC3=O)c1
c: Brc1cccc(CNc2nc3ccccc3n2CCN2CCOCC2)c1
Answer: c. Brc1cccc(CNc2nc3ccccc3n2CCN2CCOCC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Brc1cccc(CNc2nc3ccccc3n2CCN2CCOCC2)c1
Brc1cccc(CNc2nc3ccccc3n2CCN2CCOCC2)c1
N-[(3-bromophenyl)methyl]-1-(2-morpholin-4-ylethyl)benzimidazol-2-amine